Sinphar Pharmaceutical Co.,Ltd.
1734.TW
Price:
$30.6
Market Cap:
$5.82B
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods...[Read more]
Industry
Biotechnology
IPO Date
2002-08-27
Stock Exchange
TAI
Ticker
1734.TW
PE Ratio
[16.91]
ROE
[10.50%]
Current Ratio
[2.21]
Dividend Yield
[3.11%]
Enterprise Value
[6.60B]
Dividend History
The ROE as of December 2025 (TTM) for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) is 10.50%
According to Sinphar Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is 10.50%. This represents a change of 301.33% compared to the average of 2.62% of the last 4 quarters.
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Historical ROE (quarterly & annually)
How has 1734.TW ROE performed in the past?
The mean historical ROE of Sinphar Pharmaceutical Co.,Ltd. over the last ten years is 2.96%. The current 10.50% ROE has changed 254.43% with respect to the historical average. Over the past ten years (40 quarters), 1734.TW's ROE was at its highest in in the June 2023 quarter at 3.72%. The ROE was at its lowest in in the December 2020 quarter at -1.97%.
Average
2.96%
Median
0.52%
Minimum
-1.40%
Maximum
12.11%
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) ROE by Quarter and Year
Discovering the peaks and valleys of Sinphar Pharmaceutical Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 123.20%
Maximum Annual ROE = 12.11%
Minimum Annual Increase = -647.26%
Minimum Annual ROE = -1.40%
| Year | ROE | Change |
|---|---|---|
| 2024 | 9.34% | -22.89% |
| 2023 | 12.11% | 57.95% |
| 2022 | 7.67% | -647.26% |
| 2021 | -1.40% | 34.85% |
| 2020 | -1.04% | -307.09% |
| 2019 | 0.50% | 67.08% |
| 2018 | 0.30% | -74.86% |
| 2017 | 1.19% | 123.20% |
| 2016 | 0.54% | 23.46% |
| 2015 | 0.43% | -91.23% |
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Average ROE
How has 1734.TW ROE performed in the past?
The current ROE of Sinphar Pharmaceutical Co.,Ltd. (1734.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.70%
5-year avg
5.33%
10-year avg
2.96%
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) ROE vs. Peers
How is 1734.TW’s ROE compared to its peers?
Sinphar Pharmaceutical Co.,Ltd.’s ROE is greater than OBI Pharma, Inc. (-79.60%), less than Panion & Bf Biotech Inc. (9.37%), less than Savior Lifetec Corporation (13.48%), less than Hi-Clearance Inc. (11.74%), greater than TaiGen Biopharmaceuticals Holdings Limited (-18.45%), greater than Pharmosa Biopharm Inc. (-13.28%), less than Locus Cell Co., Ltd. (0%), less than Pacific Hospital Supply Co., Ltd (13.85%), greater than Mycenax Biotech Inc. (-26.16%), greater than BioGend Therapeutics Co., Ltd. (-13.11%),
| Company | ROE | Market cap |
|---|---|---|
| -79.60% | $7.76B | |
| 9.37% | $5.50B | |
| 13.48% | $5.49B | |
| 11.74% | $6.10B | |
| -18.45% | $8.61B | |
| -13.28% | $7.00B | |
| 0% | $5.77B | |
| 13.85% | $6.22B | |
| -26.16% | $6.32B | |
| -13.11% | $4.74B |
Build a custom stock screener for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinphar Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sinphar Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sinphar Pharmaceutical Co.,Ltd.'s ROE?
How is the ROE calculated for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
What is the highest ROE for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
What is the 3-year average ROE for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
What is the 5-year average ROE for Sinphar Pharmaceutical Co.,Ltd. (1734.TW)?
How does the current ROE for Sinphar Pharmaceutical Co.,Ltd. (1734.TW) compare to its historical average?